175 related articles for article (PubMed ID: 11926730)
1. Understanding changes in cholinergic function: implications for treating dementia.
J Clin Psychiatry; 2002 Mar; 63(3):259-69. PubMed ID: 11926730
[No Abstract] [Full Text] [Related]
2. Brief review: rivastigmine, a second cholinesterase inhibitor.
Patterson C; Hogan DB
Can J Neurol Sci; 2001 Feb; 28 Suppl 1():S122-3. PubMed ID: 11237306
[No Abstract] [Full Text] [Related]
3. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Moerkens RM; Dhondt AD
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
[No Abstract] [Full Text] [Related]
4. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Mol JA
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
[No Abstract] [Full Text] [Related]
5. [Acetylcholinesterase inhibitors for dementia--an update].
Anghelescu I; Heuser I
MMW Fortschr Med; 2007 May; 149 Suppl 2():76-8. PubMed ID: 17724973
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
7. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Grace J; Daniel S; Stevens T; Shankar KK; Walker Z; Byrne EJ; Butler S; Wilkinson D; Woolford J; Waite J; McKeith IG
Int Psychogeriatr; 2001 Jun; 13(2):199-205. PubMed ID: 11495394
[TBL] [Abstract][Full Text] [Related]
8. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
Finkel SI
Clin Ther; 2004 Jul; 26(7):980-90. PubMed ID: 15336465
[TBL] [Abstract][Full Text] [Related]
9. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
[TBL] [Abstract][Full Text] [Related]
10. [Rivastigmine: a review of its clinical effectiveness].
Spiegel R
Rev Neurol; 2002 Nov 1-15; 35(9):859-69. PubMed ID: 12436385
[TBL] [Abstract][Full Text] [Related]
11. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Scheepmaker AJ; Horstink MW; Hoefnagels WH; Strijks FE
Ned Tijdschr Geneeskd; 2003 Jan; 147(1):32-5. PubMed ID: 12564296
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
13. Rivastigmine in the treatment of Alzheimer's disease.
Deleu D
Eur Neurol; 2001; 46(2):110. PubMed ID: 11528167
[No Abstract] [Full Text] [Related]
14. Drug treatment of Alzheimer's disease and responders to rivastigmine beyond 12 weeks.
McMillan H
Int J Geriatr Psychiatry; 1999 Dec; 14(12):1078-9. PubMed ID: 10607978
[No Abstract] [Full Text] [Related]
15. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
McKeith I; Del Ser T; Spano P; Emre M; Wesnes K; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
Lancet; 2000 Dec; 356(9247):2031-6. PubMed ID: 11145488
[TBL] [Abstract][Full Text] [Related]
16. Rivastigmine (Exelon) for dementia in patients with Parkinson's disease.
Giladi N; Shabtai H; Gurevich T; Benbunan B; Anca M; Korczyn AD
Acta Neurol Scand; 2003 Nov; 108(5):368-73. PubMed ID: 14616309
[TBL] [Abstract][Full Text] [Related]
17. Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.
Fogelson N; Kogan E; Korczyn AD; Giladi N; Shabtai H; Neufeld MY
Acta Neurol Scand; 2003 Apr; 107(4):252-5. PubMed ID: 12675697
[TBL] [Abstract][Full Text] [Related]
18. Rivastigmine for Alzheimer's disease.
Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
[TBL] [Abstract][Full Text] [Related]
19. [Acetylcholinesterase inhibitors--beyond Alzheimer's disease].
Kłoszewska I
Psychiatr Pol; 2002; 36(6 Suppl):133-41. PubMed ID: 12647432
[TBL] [Abstract][Full Text] [Related]
20. The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.
Bullock R
Int J Clin Pract; 2002 Apr; 56(3):206-14. PubMed ID: 12018828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
